| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 BCL9L NCOA6 TOB2 VPS11 NANOGP8 UBQLN2 TCF20 RB1 WWTR1 SSX7 MED13L ARID1A GAB2 AXIN1 AP4E1 MRTFB BRD4 EPC1 IRF2BPL ZNF782 MAML3 EP300 | 8.87e-07 | 1160 | 126 | 23 | GO:0030674 |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.38e-06 | 31 | 126 | 5 | GO:0140033 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 BCL9L NCOA6 TOB2 TCF20 RB1 WWTR1 SSX7 MED13L ARID1A MRTFB BRD4 IRF2BPL MAML3 EP300 | 2.65e-06 | 562 | 126 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 BCL9L NCOA6 TOB2 VPS11 NANOGP8 UBQLN2 TCF20 RB1 WWTR1 SSX7 MED13L ARID1A GAB2 AXIN1 SGK3 AP4E1 MRTFB BRD4 EPC1 IRF2BPL ZNF782 MAML3 EP300 | 3.63e-06 | 1356 | 126 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | TRERF1 BCL9L NCOA6 TCF20 WWTR1 ARID1A MRTFB BRD4 MAML3 EP300 | 2.28e-05 | 303 | 126 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.28e-05 | 54 | 126 | 5 | GO:0001223 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.65e-05 | 30 | 126 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 NANOGP8 TOX STAG1 CHD7 RUNX1 ARID1A SALL1 BRD4 KMT2A MLLT1 CHD6 MBD5 EP300 SMAD3 | 6.60e-05 | 739 | 126 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK3 RALGAPA1 RALGAPB TSC2 RGS12 SYNGAP1 TBC1D8 ARHGAP28 ARHGAP25 | 7.06e-05 | 279 | 126 | 9 | GO:0005096 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.50e-05 | 37 | 126 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.14e-04 | 120 | 126 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.56e-04 | 17 | 126 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.59e-04 | 20 | 126 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.64e-04 | 140 | 126 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 NCOA6 TOB2 NANOGP8 RB1 RUNX1 ARID1A FOXA3 SALL1 KMT2A CHD6 EP300 EPAS1 SMAD3 | 2.89e-04 | 753 | 126 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | 5'-flap endonuclease activity | 8.13e-04 | 7 | 126 | 2 | GO:0017108 | |
| GeneOntologyMolecularFunction | flap endonuclease activity | 1.08e-03 | 8 | 126 | 2 | GO:0048256 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRERF1 NCOA6 TOB2 RB1 RUNX1 ARID1A SALL1 KMT2A EP300 EPAS1 SMAD3 | 1.16e-03 | 582 | 126 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.21e-03 | 187 | 126 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | protein domain specific binding | DOCK3 NCOA6 VPS11 RB1 TOM1L1 PLXND1 FOXA3 ELMO1 GAB2 AXIN1 SYNGAP1 SHISA9 CTR9 EXOC4 | 1.26e-03 | 875 | 126 | 14 | GO:0019904 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.27e-03 | 127 | 126 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.33e-03 | 417 | 126 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.38e-03 | 9 | 126 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.39e-03 | 262 | 126 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 RALGAPA1 RALGAPB TSC2 RGS12 ELMO1 SYNGAP1 TBC1D8 ARHGAP28 ARHGAP25 | 1.42e-03 | 507 | 126 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 RALGAPA1 RALGAPB TSC2 RGS12 ELMO1 SYNGAP1 TBC1D8 ARHGAP28 ARHGAP25 | 1.42e-03 | 507 | 126 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | p53 binding | 1.43e-03 | 77 | 126 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.89e-03 | 83 | 126 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.98e-03 | 206 | 126 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.15e-03 | 86 | 126 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.20e-03 | 41 | 126 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 2.20e-03 | 41 | 126 | 3 | GO:0000217 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 2.50e-03 | 12 | 126 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | enzyme activator activity | DOCK3 RALGAPA1 TOM1L1 RALGAPB TSC2 RGS12 SYNGAP1 TBC1D8 ARHGAP28 ARHGAP25 ALK | 2.96e-03 | 656 | 126 | 11 | GO:0008047 |
| GeneOntologyMolecularFunction | kinase binding | CYLD RB1 TOM1L1 RFFL CEP192 LYST RYR2 GAB2 AXIN1 SYNGAP1 CPNE3 EP300 SMAD1 SMAD3 | 3.22e-03 | 969 | 126 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | helicase activity | 3.30e-03 | 158 | 126 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.35e-03 | 229 | 126 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 3.42e-03 | 14 | 126 | 2 | GO:0016888 | |
| GeneOntologyMolecularFunction | protein kinase binding | CYLD TOM1L1 RFFL CEP192 LYST RYR2 GAB2 AXIN1 SYNGAP1 CPNE3 EP300 SMAD1 SMAD3 | 3.50e-03 | 873 | 126 | 13 | GO:0019901 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 BCL9L NCOA6 NANOGP8 TCF20 TOX RB1 TSC2 WWTR1 CHD7 RUNX1 FOXA3 BSX MRTFB SALL1 CTR9 BRD4 EPC1 KMT2A IRF2BPL CHD6 ZNF782 MAML3 EP300 EPAS1 SMAD1 SMAD3 | 7.69e-08 | 1390 | 127 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 7.40e-06 | 162 | 127 | 8 | GO:0045621 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 1.18e-05 | 124 | 127 | 7 | GO:0001704 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.93e-05 | 242 | 127 | 9 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.93e-05 | 242 | 127 | 9 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 3.10e-05 | 144 | 127 | 7 | GO:0045582 | |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 6.19e-05 | 35 | 127 | 4 | GO:0043369 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | CYLD BCL9L TOX RB1 WWTR1 PLXND1 RUNX1 ARID1A CR1 FOXA3 BNC1 SALL1 BRD4 EPC1 BTN2A3P CDH4 EP300 SMAD1 SMAD3 | 7.07e-05 | 1141 | 127 | 19 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 8.04e-05 | 226 | 127 | 8 | GO:0045580 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 1.28e-04 | 42 | 127 | 4 | GO:0002360 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.29e-04 | 382 | 127 | 10 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of cell development | CYLD TOB2 TOX RB1 TSC2 CHD7 PLXND1 RUNX1 ARID1A CR1 SYNGAP1 BNC1 CTR9 BRD4 SLIT1 BTN2A3P CDH4 EP300 | 1.31e-04 | 1095 | 127 | 18 | GO:0060284 |
| GeneOntologyBiologicalProcess | mesoderm formation | 1.53e-04 | 82 | 127 | 5 | GO:0001707 | |
| GeneOntologyBiologicalProcess | regulation of binding | 1.73e-04 | 396 | 127 | 10 | GO:0051098 | |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 1.91e-04 | 86 | 127 | 5 | GO:0048332 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.39e-04 | 336 | 127 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | heart development | NCOA6 RB1 TSC2 CHD7 PLXND1 RUNX1 ARID1A RYR2 MRTFB SALL1 GYS1 EP300 SMAD1 SMAD3 | 2.39e-04 | 757 | 127 | 14 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 2.46e-04 | 266 | 127 | 8 | GO:0045619 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.49e-04 | 338 | 127 | 9 | GO:0045165 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | RALGAPA1 NR2C1 NANOGP8 MCPH1 RB1 CPEB3 WWTR1 RUNX1 ARID1A HOXC8 SALL1 CTR9 EPC1 IRF2BPL EP300 EPAS1 SMAD3 | 2.54e-04 | 1053 | 127 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.78e-04 | 343 | 127 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | positive T cell selection | 3.18e-04 | 53 | 127 | 4 | GO:0043368 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | TOB2 NANOGP8 RB1 TSC2 WWTR1 RUNX1 CR1 AXIN1 SYNGAP1 SALL1 CTR9 SLIT1 USH2A SMAD1 SMAD3 | 3.20e-04 | 875 | 127 | 15 | GO:0045596 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 3.28e-04 | 429 | 127 | 10 | GO:1902105 | |
| GeneOntologyBiologicalProcess | gastrulation | 3.46e-04 | 212 | 127 | 7 | GO:0007369 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 RALGAPA1 NR2C1 TOB2 NANOGP8 MCPH1 RB1 CPEB3 WWTR1 RUNX1 ARID1A AXIN1 HOXC8 SALL1 CTR9 EPC1 IRF2BPL EP300 EPAS1 SMAD3 | 3.48e-04 | 1399 | 127 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | DOCK3 BCL9L NANOGP8 TOM1L1 TSC2 WWTR1 GAB2 AXIN1 LRIG2 MST1R WFIKKN2 CPNE3 INTS9 MBD5 ALK EP300 SMAD1 SMAD3 | 3.49e-04 | 1186 | 127 | 18 | GO:0007167 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 RALGAPA1 NR2C1 TOB2 NANOGP8 MCPH1 RB1 CPEB3 WWTR1 RUNX1 ARID1A AXIN1 HOXC8 SALL1 CTR9 EPC1 IRF2BPL EP300 EPAS1 SMAD3 | 3.95e-04 | 1413 | 127 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | CYLD TOX RB1 PLXND1 RUNX1 ARID1A CR1 BNC1 BRD4 BTN2A3P CDH4 EP300 | 4.16e-04 | 614 | 127 | 12 | GO:0010720 |
| GeneOntologyBiologicalProcess | mesoderm development | 4.28e-04 | 157 | 127 | 6 | GO:0007498 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA6 SHROOM3 TSC2 CHD7 RUNX1 ARID1A CR1 AXIN1 MRTFB SALL1 CTR9 BRD4 EP300 EPAS1 SMAD3 | 4.62e-04 | 906 | 127 | 15 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development | NCOA6 SHROOM3 NANOGP8 TSC2 CHD7 RUNX1 ARID1A CR1 RYR2 AXIN1 MRTFB SALL1 CTR9 BRD4 KMT2A EP300 EPAS1 SMAD1 SMAD3 EXOC4 | 4.90e-04 | 1437 | 127 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 5.16e-04 | 540 | 127 | 11 | GO:1903706 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 TOX MCPH1 CHD7 ARID1A CA10 AXIN1 SHROOM4 MRTFB SALL1 SLIT1 WDR89 ALK EP300 SMAD1 | 5.35e-04 | 919 | 127 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | resolution of DNA recombination intermediates | 5.55e-04 | 6 | 127 | 2 | GO:0071139 | |
| GeneOntologyBiologicalProcess | growth | RB1 WWTR1 CHD7 MUC12 RUNX1 SGK3 EYS SALL1 CSF2RB CTR9 FUBP1 BRD4 SLIT1 MBD5 CDH4 EP300 SMAD1 SMAD3 | 5.64e-04 | 1235 | 127 | 18 | GO:0040007 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA6 SHROOM3 TSC2 CHD7 RUNX1 ARID1A CR1 AXIN1 MRTFB SALL1 CTR9 BRD4 EP300 EPAS1 SMAD3 | 5.99e-04 | 929 | 127 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 6.41e-04 | 385 | 127 | 9 | GO:0051251 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 6.73e-04 | 237 | 127 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | embryonic organ development | NCOA6 CHD7 RUNX1 ARID1A RYR2 AXIN1 MRTFB SALL1 KMT2A EPAS1 SMAD3 | 7.07e-04 | 561 | 127 | 11 | GO:0048568 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SHROOM3 NANOGP8 TSC2 CHD7 PLXND1 RUNX1 ARID1A RYR2 AXIN1 SALL1 SMAD1 SMAD3 EXOC4 | 7.38e-04 | 750 | 127 | 13 | GO:0048729 |
| Domain | DUF4599 | 7.84e-11 | 12 | 127 | 6 | PF15371 | |
| Domain | DUF4599 | 7.84e-11 | 12 | 127 | 6 | IPR027970 | |
| Domain | ARM-type_fold | DOCK3 RALGAPA1 VPS11 UBQLN2 STAG1 PKP4 TSC2 ARID1A LYST ELMO1 AP4E1 SYMPK | 3.50e-06 | 339 | 127 | 12 | IPR016024 |
| Domain | Rap_GAP_dom | 4.87e-05 | 11 | 127 | 3 | IPR000331 | |
| Domain | RAPGAP | 4.87e-05 | 11 | 127 | 3 | PS50085 | |
| Domain | NPIP | 1.06e-04 | 14 | 127 | 3 | IPR009443 | |
| Domain | Shroom_fam | 2.73e-04 | 4 | 127 | 2 | IPR027685 | |
| Domain | ASD2_dom | 2.73e-04 | 4 | 127 | 2 | IPR014799 | |
| Domain | ASD2 | 2.73e-04 | 4 | 127 | 2 | PF08687 | |
| Domain | ASD2 | 2.73e-04 | 4 | 127 | 2 | PS51307 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | NR2C1 RB1 PSMB3 RFFL TSC2 WWTR1 RUNX1 ARID1A CR1 AXIN1 CTR9 EPC1 KMT2A MLLT1 INTS9 ZNF782 DNA2 MAML3 EP300 TOP3A SMAD1 SMAD3 SYMPK | 1.68e-05 | 1387 | 91 | 23 | M734 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | NR2C1 PSMB3 RFFL TSC2 WWTR1 ARID1A CTR9 EPC1 KMT2A MLLT1 INTS9 ZNF782 DNA2 MAML3 EP300 TOP3A SMAD1 SMAD3 SYMPK | 2.28e-05 | 1022 | 91 | 19 | MM15436 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.56e-05 | 96 | 91 | 6 | M27784 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | NR2C1 PSMB3 RFFL TSC2 WWTR1 ARID1A EPC1 KMT2A ZNF782 DNA2 MAML3 EP300 TOP3A SMAD1 SMAD3 | 1.10e-04 | 768 | 91 | 15 | MM14851 |
| Pubmed | 3.14e-09 | 6 | 134 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 3.14e-09 | 6 | 134 | 4 | 25930072 | |
| Pubmed | TRERF1 CYLD BCL9L NR2C1 NCOA6 TCF20 RB1 PSMB3 R3HDM2 CHD7 CEP192 ARID1A ANKHD1 SALL1 FUBP1 EPC1 KMT2A MLLT1 IRF2BPL CHD6 EP300 EXOC4 SYMPK | 6.05e-09 | 1429 | 134 | 23 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 CYLD NCOA6 SHROOM3 TCF20 PPFIA1 RALGAPB TSC2 WWTR1 CEP192 LYST RGS12 GAB2 STARD9 BRD4 KMT2A GEN1 EXOC4 | 6.39e-09 | 861 | 134 | 18 | 36931259 |
| Pubmed | TRERF1 BCL9L NCOA6 TCF20 CHD7 MED13L ARID1A CTR9 BRD4 EPC1 KMT2A | 8.25e-09 | 268 | 134 | 11 | 33640491 | |
| Pubmed | 1.90e-08 | 225 | 134 | 10 | 12168954 | ||
| Pubmed | 4.35e-08 | 10 | 134 | 4 | 16890162 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 DOCK3 NCOA6 TOB2 SHROOM3 UBQLN2 CHD7 SYNGAP1 MRTFB SALL1 IRF2BPL SMAD1 | 1.19e-07 | 430 | 134 | 12 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 BCL9L NR2C1 NCOA6 TCF20 CHD7 ARID1A SALL1 EPC1 KMT2A EP300 | 1.29e-07 | 351 | 134 | 11 | 38297188 |
| Pubmed | NR2C1 TCF20 MCPH1 STAG1 MED13L RUNX1 ARID1A SMC5 FUBP1 INTS9 EP300 TOP3A | 2.07e-07 | 453 | 134 | 12 | 29656893 | |
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 5.56e-07 | 5 | 134 | 3 | 10497242 | |
| Pubmed | CYLD TOB2 TCF20 RALGAPB R3HDM2 CEP192 MED13L SMC5 STARD9 SLIT1 CHD6 | 5.59e-07 | 407 | 134 | 11 | 12693553 | |
| Pubmed | TRERF1 NR2C1 TCF20 PPFIA1 CHD7 ANKHD1 MRTFB SALL1 BRD4 CHD6 EXOC4 | 7.26e-07 | 418 | 134 | 11 | 34709266 | |
| Pubmed | 8.65e-07 | 83 | 134 | 6 | 28794006 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.96e-07 | 341 | 134 | 10 | 32971831 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 NCOA6 SHROOM3 TSC2 CEP192 PLXND1 MED13L ARID1A ANKHD1 LYST MST1R BRD4 MLLT1 MBD5 EP300 TOP3A SYMPK | 1.30e-06 | 1105 | 134 | 17 | 35748872 |
| Pubmed | RALGAPA1 CYLD BCL9L SHROOM3 PPFIA1 PKP4 RALGAPB R3HDM2 TSC2 CEP192 ARID1A | 1.36e-06 | 446 | 134 | 11 | 24255178 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA6 TCF20 PSMB3 WWTR1 ARID1A ANKHD1 FUBP1 FAM222B MAML3 EP300 | 1.73e-06 | 457 | 134 | 11 | 32344865 |
| Pubmed | 2.11e-06 | 24 | 134 | 4 | 32212159 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 TCF20 MCPH1 WWTR1 CHD7 RUNX1 ARID1A CTR9 BRD4 EPC1 KMT2A WDR89 MLLT1 INTS9 CHD6 EP300 TOP3A SYMPK | 2.57e-06 | 1294 | 134 | 18 | 30804502 |
| Pubmed | 2.71e-06 | 157 | 134 | 7 | 30186101 | ||
| Pubmed | NEDDylation controls the target specificity of E2F1 and apoptosis induction. | 3.09e-06 | 8 | 134 | 3 | 23001041 | |
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 10531362 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD RB1 CHD7 CEP192 ARID1A TBC1D8 MRTFB SALL1 CTR9 CPNE3 TOP3A EXOC4 | 3.16e-06 | 588 | 134 | 12 | 38580884 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NR2C1 NCOA6 TCF20 NVL CHD7 ARID1A SMC5 CS SALL1 FUBP1 BRD4 KMT2A MLLT1 ALK SYMPK | 4.41e-06 | 954 | 134 | 15 | 36373674 |
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 16801560 | ||
| Pubmed | 6.58e-06 | 10 | 134 | 3 | 12665591 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 7.26e-06 | 69 | 134 | 5 | 28481362 | |
| Pubmed | 7.44e-06 | 183 | 134 | 7 | 36129980 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 8.36e-06 | 71 | 134 | 5 | 28319113 | |
| Pubmed | NCOA6 TCF20 WWTR1 ARID1A ANKHD1 MRTFB BRD4 KMT2A EP300 EXOC4 SYMPK | 9.83e-06 | 549 | 134 | 11 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 NCOA6 TCF20 RALGAPB RFFL CHD7 RUNX1 CTR9 FUBP1 BRD4 KMT2A IRF2BPL SYMPK | 9.94e-06 | 774 | 134 | 13 | 15302935 |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 35715442 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 36435883 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16876108 | ||
| Pubmed | Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia. | 1.47e-05 | 2 | 134 | 2 | 8378076 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 35839978 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28739802 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 36274096 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21493871 | ||
| Pubmed | Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-beta effectors. | 1.47e-05 | 2 | 134 | 2 | 20147459 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17252016 | ||
| Pubmed | MLL becomes functional through intra-molecular interaction not by proteolytic processing. | 1.47e-05 | 2 | 134 | 2 | 24040009 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21953510 | ||
| Pubmed | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. | 1.47e-05 | 2 | 134 | 2 | 21964340 | |
| Pubmed | Haploinsufficiency of the MLL and TOB2 genes in lymphoid malignancy. | 1.47e-05 | 2 | 134 | 2 | 19940862 | |
| Pubmed | Molecules mimicking Smad1 interacting with Hox stimulate bone formation. | 1.47e-05 | 2 | 134 | 2 | 14672939 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19029444 | ||
| Pubmed | NCOA6 UBQLN2 STAG1 RYR2 MRTFB CTR9 BRD4 CHD6 EPAS1 SMAD1 SMAD3 | 1.94e-05 | 591 | 134 | 11 | 15231748 | |
| Pubmed | 1.97e-05 | 14 | 134 | 3 | 11472062 | ||
| Pubmed | 1.97e-05 | 14 | 134 | 3 | 16790475 | ||
| Pubmed | TRERF1 NR2C1 NCOA6 TCF20 PSMB3 CHD7 MED13L RUNX1 ARID1A ELMO1 CTR9 FUBP1 BRD4 KMT2A EP300 | 2.43e-05 | 1103 | 134 | 15 | 34189442 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.45e-05 | 220 | 134 | 7 | 35785414 | |
| Pubmed | 3.02e-05 | 16 | 134 | 3 | 23870121 | ||
| Pubmed | 3.03e-05 | 46 | 134 | 4 | 21102462 | ||
| Pubmed | 3.53e-05 | 233 | 134 | 7 | 37704626 | ||
| Pubmed | DOCK3 CYLD NR2C1 UBQLN2 STAG1 TSC2 MED13L RUNX1 ARID1A SYNGAP1 CS CTR9 CHD6 GEN1 EP300 EXOC4 | 3.73e-05 | 1285 | 134 | 16 | 35914814 | |
| Pubmed | TCF20 RB1 PSMB3 NVL MED13L SMC5 CTR9 FUBP1 BRD4 CPNE3 KMT2A IRF2BPL EP300 SYMPK | 3.92e-05 | 1014 | 134 | 14 | 32416067 | |
| Pubmed | 4.37e-05 | 18 | 134 | 3 | 21030982 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20851880 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11134049 | ||
| Pubmed | Identification of functional cooperative mutations of SETD2 in human acute leukemia. | 4.41e-05 | 3 | 134 | 2 | 24509477 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20019387 | ||
| Pubmed | Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer. | 4.41e-05 | 3 | 134 | 2 | 28055379 | |
| Pubmed | Construction of a D2.B6-Fv-2r congenic mouse strain: nonlethality of the homozygous Fv-2' genotype. | 4.41e-05 | 3 | 134 | 2 | 6939921 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 33933467 | ||
| Pubmed | The Smad3 linker region contains a transcriptional activation domain. | 4.41e-05 | 3 | 134 | 2 | 15588252 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 10995463 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 22219182 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16433901 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 23303459 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28262505 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 14645241 | ||
| Pubmed | The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. | 4.41e-05 | 3 | 134 | 2 | 25689462 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 26916619 | ||
| Pubmed | Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. | 4.41e-05 | 3 | 134 | 2 | 33563892 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 30500954 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20564330 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 18263591 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28533432 | ||
| Pubmed | Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4. | 4.41e-05 | 3 | 134 | 2 | 30224758 | |
| Pubmed | The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells. | 4.41e-05 | 3 | 134 | 2 | 15345715 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 22615489 | ||
| Pubmed | Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. | 4.41e-05 | 3 | 134 | 2 | 25234806 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 1423624 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 18829457 | ||
| Pubmed | Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide. | 4.41e-05 | 3 | 134 | 2 | 18829459 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 10962029 | ||
| Pubmed | Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice. | 4.41e-05 | 3 | 134 | 2 | 32544088 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19520869 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 30002389 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9843571 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12781363 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15066998 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15824515 | ||
| Pubmed | Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies. | 4.41e-05 | 3 | 134 | 2 | 26355662 | |
| Pubmed | Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation. | 4.41e-05 | 3 | 134 | 2 | 19359245 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 39108258 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 36250963 | ||
| Pubmed | RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling. | 4.41e-05 | 3 | 134 | 2 | 33686240 | |
| Interaction | AR interactions | TRERF1 BCL9L NR2C1 NCOA6 TCF20 RB1 PSMB3 NVL CHD7 MED13L RUNX1 ARID1A CTR9 FUBP1 BRD4 EPC1 CPNE3 KMT2A IRF2BPL EP300 SMAD1 SMAD3 SYMPK | 5.49e-08 | 992 | 127 | 23 | int:AR |
| Interaction | SMARCC1 interactions | MCPH1 WWTR1 CHD7 RUNX1 ARID1A SMC5 FUBP1 BRD4 KMT2A MLLT1 EP300 EPAS1 SMAD3 SYMPK | 1.45e-07 | 384 | 127 | 14 | int:SMARCC1 |
| Interaction | MED15 interactions | 1.46e-07 | 131 | 127 | 9 | int:MED15 | |
| Interaction | SMARCC2 interactions | MCPH1 CHD7 RUNX1 ARID1A SMC5 FUBP1 BRD4 KMT2A MLLT1 EP300 EPAS1 SMAD3 SYMPK | 3.70e-07 | 353 | 127 | 13 | int:SMARCC2 |
| Interaction | CRX interactions | TRERF1 BCL9L NR2C1 TCF20 CHD7 ARID1A SALL1 GYS1 EPC1 EP300 SMAD3 | 6.30e-07 | 254 | 127 | 11 | int:CRX |
| Interaction | RBBP7 interactions | NR2C1 TCF20 STAG1 RB1 WWTR1 ARID1A SMC5 ANKHD1 SALL1 BRD4 SHPRH KMT2A ARHGAP25 EP300 SYMPK | 7.33e-07 | 507 | 127 | 15 | int:RBBP7 |
| Interaction | TLE3 interactions | TRERF1 BCL9L TCF20 RUNX1 ARID1A FOXA3 SGK3 HOXC8 SALL1 BRD4 KMT2A CHD6 EP300 | 7.54e-07 | 376 | 127 | 13 | int:TLE3 |
| Interaction | SIN3A interactions | NR2C1 TCF20 WWTR1 RUNX1 ARID1A FUBP1 BRD4 SHPRH KMT2A EP300 EPAS1 SMAD3 SYMPK | 8.49e-07 | 380 | 127 | 13 | int:SIN3A |
| Interaction | RUNX2 interactions | 1.34e-06 | 126 | 127 | 8 | int:RUNX2 | |
| Interaction | EGR2 interactions | 1.39e-06 | 171 | 127 | 9 | int:EGR2 | |
| Interaction | MAPK1 interactions | UBQLN2 TCF20 RB1 RFFL TSC2 RUNX1 GAB2 SYNGAP1 MRTFB PTPRH BRD4 ALK EP300 SMAD1 SMAD3 | 1.72e-06 | 543 | 127 | 15 | int:MAPK1 |
| Interaction | MBD3 interactions | NR2C1 STAG1 RUNX1 ARID1A SMC5 SALL1 BRD4 SHPRH KMT2A EXOC4 SYMPK | 2.71e-06 | 295 | 127 | 11 | int:MBD3 |
| Interaction | SMAD1 interactions | NCOA6 TCF20 RUNX1 ARID1A MRTFB HOXC8 CPNE3 EP300 SMAD1 SMAD3 | 3.29e-06 | 243 | 127 | 10 | int:SMAD1 |
| Interaction | RBBP4 interactions | CYLD NR2C1 TCF20 STAG1 RB1 CHD7 RUNX1 ARID1A SMC5 SALL1 BRD4 SHPRH KMT2A EP300 SYMPK | 3.32e-06 | 573 | 127 | 15 | int:RBBP4 |
| Interaction | MTA2 interactions | NR2C1 TCF20 STAG1 WWTR1 CHD7 RUNX1 ARID1A SALL1 BRD4 SHPRH EP300 SMAD3 SYMPK | 3.78e-06 | 435 | 127 | 13 | int:MTA2 |
| Interaction | NCOA6 interactions | 3.85e-06 | 145 | 127 | 8 | int:NCOA6 | |
| Interaction | YWHAH interactions | RALGAPA1 CYLD NCOA6 SHROOM3 TCF20 PPFIA1 RALGAPB R3HDM2 TSC2 WWTR1 CEP192 LYST RGS12 GAB2 SYNGAP1 MST1R STARD9 BRD4 KMT2A GEN1 EXOC4 | 5.20e-06 | 1102 | 127 | 21 | int:YWHAH |
| Interaction | FEV interactions | 5.69e-06 | 203 | 127 | 9 | int:FEV | |
| Interaction | RUNX1 interactions | WWTR1 RUNX1 ARID1A FUBP1 FAM222B KMT2A MLLT1 INTS9 EP300 SMAD1 SMAD3 | 6.64e-06 | 324 | 127 | 11 | int:RUNX1 |
| Interaction | SMARCA4 interactions | NR2C1 MCPH1 RB1 WWTR1 CHD7 RUNX1 ARID1A SMC5 BRD4 MLLT1 EP300 EPAS1 SMAD3 | 7.24e-06 | 462 | 127 | 13 | int:SMARCA4 |
| Interaction | TFAP2A interactions | 7.86e-06 | 114 | 127 | 7 | int:TFAP2A | |
| Interaction | MTA1 interactions | 1.25e-05 | 283 | 127 | 10 | int:MTA1 | |
| Interaction | RBBP5 interactions | 1.42e-05 | 287 | 127 | 10 | int:RBBP5 | |
| Interaction | SMARCE1 interactions | 1.42e-05 | 287 | 127 | 10 | int:SMARCE1 | |
| Interaction | TLX3 interactions | BCL9L NR2C1 NCOA6 TCF20 CHD7 ARID1A SYNGAP1 SALL1 CHD6 EP300 | 1.60e-05 | 291 | 127 | 10 | int:TLX3 |
| Interaction | YAP1 interactions | TRERF1 BCL9L NCOA6 UBQLN2 TCF20 RB1 WWTR1 RUNX1 ARID1A AXIN1 MRTFB GLB1 FUBP1 BRD4 CPNE3 KMT2A EP300 SMAD1 SMAD3 SYMPK | 1.67e-05 | 1095 | 127 | 20 | int:YAP1 |
| Interaction | PAX9 interactions | 1.86e-05 | 130 | 127 | 7 | int:PAX9 | |
| Interaction | PAX6 interactions | NR2C1 NCOA6 RB1 CHD7 ARID1A HOXC8 SALL1 CHD6 EP300 SMAD1 SMAD3 | 2.07e-05 | 366 | 127 | 11 | int:PAX6 |
| Interaction | SP7 interactions | 2.32e-05 | 304 | 127 | 10 | int:SP7 | |
| Interaction | FOS interactions | 2.90e-05 | 312 | 127 | 10 | int:FOS | |
| Interaction | KMT2A interactions | 3.06e-05 | 314 | 127 | 10 | int:KMT2A | |
| Interaction | TP53BP1 interactions | NR2C1 NCOA6 MCPH1 WWTR1 MED13L ARID1A SMC5 SYNGAP1 FUBP1 BRD4 INTS9 EP300 EXOC4 | 3.26e-05 | 533 | 127 | 13 | int:TP53BP1 |
| Interaction | KLF5 interactions | 3.34e-05 | 195 | 127 | 8 | int:KLF5 | |
| Interaction | SOX9 interactions | 3.44e-05 | 97 | 127 | 6 | int:SOX9 | |
| Interaction | SS18L1 interactions | 3.65e-05 | 98 | 127 | 6 | int:SS18L1 | |
| Interaction | CCK interactions | 3.89e-05 | 11 | 127 | 3 | int:CCK | |
| Interaction | RUNX3 interactions | 4.12e-05 | 61 | 127 | 5 | int:RUNX3 | |
| Interaction | DVL1 interactions | 4.86e-05 | 151 | 127 | 7 | int:DVL1 | |
| Interaction | ARID1A interactions | 6.45e-05 | 276 | 127 | 9 | int:ARID1A | |
| Interaction | HDAC1 interactions | TRERF1 NR2C1 TCF20 STAG1 RB1 PPFIA1 RUNX1 ARID1A ANKHD1 MRTFB SALL1 BRD4 KMT2A EP300 EPAS1 SMAD1 SMAD3 EXOC4 SYMPK | 6.51e-05 | 1108 | 127 | 19 | int:HDAC1 |
| Interaction | SMARCA2 interactions | 6.91e-05 | 346 | 127 | 10 | int:SMARCA2 | |
| Interaction | PAX8 interactions | 7.34e-05 | 111 | 127 | 6 | int:PAX8 | |
| Interaction | YWHAZ interactions | RALGAPA1 CYLD SHROOM3 PPFIA1 RALGAPB R3HDM2 TSC2 WWTR1 CEP192 ARID1A SMC5 LYST RGS12 GAB2 SYNGAP1 MST1R CSF2RB STARD9 BRD4 KMT2A EP300 | 7.50e-05 | 1319 | 127 | 21 | int:YWHAZ |
| Interaction | WWTR1 interactions | NCOA6 TCF20 RB1 WWTR1 RUNX1 ARID1A ANKHD1 BRD4 KMT2A EP300 EXOC4 | 7.52e-05 | 422 | 127 | 11 | int:WWTR1 |
| Interaction | E2F5 interactions | 7.58e-05 | 36 | 127 | 4 | int:E2F5 | |
| Interaction | NUP35 interactions | BCL9L NCOA6 TCF20 PSMB3 WWTR1 ARID1A ANKHD1 FUBP1 FAM222B MAML3 EP300 | 7.85e-05 | 424 | 127 | 11 | int:NUP35 |
| Interaction | TBR1 interactions | 8.10e-05 | 113 | 127 | 6 | int:TBR1 | |
| Interaction | CHD4 interactions | NR2C1 UBQLN2 TCF20 MCPH1 ARID1A SMC5 ANKHD1 SGK3 SALL1 CTR9 BRD4 CPNE3 SHPRH KMT2A INTS9 EP300 EPAS1 | 8.41e-05 | 938 | 127 | 17 | int:CHD4 |
| Interaction | ACTL6A interactions | 9.16e-05 | 289 | 127 | 9 | int:ACTL6A | |
| Interaction | SAP30 interactions | 9.18e-05 | 167 | 127 | 7 | int:SAP30 | |
| Interaction | TBXT interactions | 9.37e-05 | 116 | 127 | 6 | int:TBXT | |
| Interaction | HCFC1 interactions | 1.02e-04 | 293 | 127 | 9 | int:HCFC1 | |
| Interaction | TWIST1 interactions | 1.03e-04 | 170 | 127 | 7 | int:TWIST1 | |
| Interaction | YWHAG interactions | RALGAPA1 CYLD NCOA6 SHROOM3 PPFIA1 RALGAPB R3HDM2 TSC2 WWTR1 CEP192 LYST RGS12 GAB2 SYNGAP1 MST1R STARD9 SHPRH KMT2A GEN1 EXOC4 | 1.04e-04 | 1248 | 127 | 20 | int:YWHAG |
| Interaction | SMARCB1 interactions | 1.05e-04 | 364 | 127 | 10 | int:SMARCB1 | |
| Interaction | MED16 interactions | 1.13e-04 | 120 | 127 | 6 | int:MED16 | |
| Interaction | MLLT1 interactions | 1.29e-04 | 123 | 127 | 6 | int:MLLT1 | |
| Interaction | FOXO3 interactions | 1.35e-04 | 124 | 127 | 6 | int:FOXO3 | |
| Interaction | KHSRP interactions | 1.48e-04 | 308 | 127 | 9 | int:KHSRP | |
| Interaction | ELL interactions | 1.51e-04 | 80 | 127 | 5 | int:ELL | |
| Interaction | SMAD7 interactions | 1.54e-04 | 127 | 127 | 6 | int:SMAD7 | |
| Interaction | GATAD2B interactions | 1.64e-04 | 245 | 127 | 8 | int:GATAD2B | |
| Interaction | SMAD2 interactions | 1.66e-04 | 385 | 127 | 10 | int:SMAD2 | |
| Interaction | SOX7 interactions | 1.70e-04 | 82 | 127 | 5 | int:SOX7 | |
| Interaction | JUN interactions | CYLD NCOA6 TCF20 RB1 RUNX1 SMC5 HOXC8 BRD4 EP300 EPAS1 SMAD3 | 1.93e-04 | 470 | 127 | 11 | int:JUN |
| Interaction | TERF2IP interactions | NR2C1 NCOA6 TCF20 RB1 CHD7 ARID1A BRD4 CPNE3 KMT2A INTS9 EPAS1 SYMPK | 1.95e-04 | 552 | 127 | 12 | int:TERF2IP |
| Interaction | PARP1 interactions | CYLD NR2C1 NCOA6 STAG1 RB1 NVL CHD7 SMC5 MST1R CTR9 STARD9 FUBP1 BRD4 SHPRH MLLT1 CHD6 MBD5 EP300 TOP3A SMAD3 | 2.12e-04 | 1316 | 127 | 20 | int:PARP1 |
| Interaction | YWHAB interactions | RALGAPA1 CYLD SHROOM3 PPFIA1 RALGAPB R3HDM2 TSC2 WWTR1 CEP192 LYST RGS12 GAB2 MST1R CS CTR9 STARD9 KMT2A | 2.14e-04 | 1014 | 127 | 17 | int:YWHAB |
| Interaction | DBP interactions | 2.20e-04 | 19 | 127 | 3 | int:DBP | |
| Interaction | GSC interactions | 2.24e-04 | 87 | 127 | 5 | int:GSC | |
| Interaction | MYOD1 interactions | 2.32e-04 | 194 | 127 | 7 | int:MYOD1 | |
| Interaction | DDX19A interactions | 2.37e-04 | 88 | 127 | 5 | int:DDX19A | |
| Interaction | SNW1 interactions | SHROOM3 STAG1 RB1 CHD7 ARID1A SMC5 FUBP1 BRD4 CPNE3 KMT2A EP300 SMAD3 EXOC4 SYMPK | 2.64e-04 | 747 | 127 | 14 | int:SNW1 |
| Interaction | GATA2 interactions | 2.71e-04 | 199 | 127 | 7 | int:GATA2 | |
| Interaction | E2F1 interactions | 2.79e-04 | 200 | 127 | 7 | int:E2F1 | |
| Interaction | KDM1A interactions | TRERF1 NR2C1 VPS11 TCF20 MCPH1 RB1 PPFIA1 CHD7 ANKHD1 MRTFB BRD4 CHD6 EP300 EPAS1 EXOC4 SYMPK | 2.84e-04 | 941 | 127 | 16 | int:KDM1A |
| Interaction | MED23 interactions | 2.87e-04 | 266 | 127 | 8 | int:MED23 | |
| Interaction | MED17 interactions | 2.97e-04 | 202 | 127 | 7 | int:MED17 | |
| Interaction | FUS interactions | CYLD NCOA6 UBQLN2 TOX PPFIA1 RUNX1 ARID1A SMC5 CTR9 BRD4 CDH4 GEN1 EP300 SYMPK | 3.02e-04 | 757 | 127 | 14 | int:FUS |
| Interaction | TCF20 interactions | 3.28e-04 | 146 | 127 | 6 | int:TCF20 | |
| Interaction | MED1 interactions | 3.34e-04 | 206 | 127 | 7 | int:MED1 | |
| Interaction | SOX17 interactions | 3.38e-04 | 95 | 127 | 5 | int:SOX17 | |
| Interaction | HDAC2 interactions | NR2C1 TCF20 STAG1 RB1 RUNX1 ARID1A SMC5 FOXA3 SALL1 FUBP1 BRD4 KMT2A EP300 EPAS1 SYMPK | 3.62e-04 | 865 | 127 | 15 | int:HDAC2 |
| Interaction | RTF1 interactions | 3.79e-04 | 150 | 127 | 6 | int:RTF1 | |
| Interaction | HIPK2 interactions | 3.90e-04 | 98 | 127 | 5 | int:HIPK2 | |
| Interaction | CREBBP interactions | TRERF1 NCOA6 RB1 WWTR1 RUNX1 ARID1A BRD4 KMT2A EP300 EPAS1 SMAD1 SMAD3 | 4.09e-04 | 599 | 127 | 12 | int:CREBBP |
| Interaction | PAF1 interactions | 4.20e-04 | 214 | 127 | 7 | int:PAF1 | |
| Interaction | SMAD5 interactions | 4.49e-04 | 101 | 127 | 5 | int:SMAD5 | |
| Interaction | TRIP6 interactions | CYLD UBQLN2 WWTR1 AXIN1 SYNGAP1 HOXC8 FAM222B TSGA10IP SMAD1 | 4.49e-04 | 358 | 127 | 9 | int:TRIP6 |
| Interaction | RARG interactions | 4.90e-04 | 58 | 127 | 4 | int:RARG | |
| Interaction | KDM1B interactions | 4.90e-04 | 58 | 127 | 4 | int:KDM1B | |
| Interaction | KDM2A interactions | 4.91e-04 | 103 | 127 | 5 | int:KDM2A | |
| Interaction | CSTF2T interactions | 5.36e-04 | 105 | 127 | 5 | int:CSTF2T | |
| Interaction | ETV6 interactions | 5.36e-04 | 105 | 127 | 5 | int:ETV6 | |
| Interaction | RARA interactions | 5.37e-04 | 223 | 127 | 7 | int:RARA | |
| Interaction | SMAD3 interactions | 5.41e-04 | 447 | 127 | 10 | int:SMAD3 | |
| Interaction | GATAD2A interactions | 5.52e-04 | 224 | 127 | 7 | int:GATAD2A | |
| Interaction | MBD2 interactions | 5.52e-04 | 161 | 127 | 6 | int:MBD2 | |
| Interaction | CCNT1 interactions | 5.67e-04 | 225 | 127 | 7 | int:CCNT1 | |
| Interaction | CRK interactions | 5.69e-04 | 370 | 127 | 9 | int:CRK | |
| Cytoband | 16p12.2 | 1.76e-04 | 37 | 134 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 2.34e-04 | 8 | 134 | 2 | chr9q12 | |
| Cytoband | 16p13.12 | 3.75e-04 | 10 | 134 | 2 | 16p13.12 | |
| GeneFamily | SMAD family | 5.73e-04 | 8 | 83 | 2 | 750 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP | 7.44e-07 | 199 | 131 | 9 | M5694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STAG1 RB1 PPFIA1 PKP4 NVL R3HDM2 MED13L RUNX1 NPIPB5 SMC5 FUBP1 SMAD3 | 4.07e-06 | 466 | 131 | 12 | M13522 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RALGAPA1 NCOA6 TCF20 TOX RB1 PPFIA1 R3HDM2 RFFL CHD7 SMC5 ANKHD1 CDC37L1 SYNGAP1 MRTFB EPC1 CDH4 GEN1 SMAD3 EXOC4 | 4.55e-07 | 831 | 126 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RALGAPA1 NCOA6 TCF20 PPFIA1 R3HDM2 RFFL CHD7 SMC5 ANKHD1 CDC37L1 GAB2 SYNGAP1 MRTFB EPC1 MBD5 MAML3 EXOC4 | 3.70e-06 | 780 | 126 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NPIPB4 STAG1 NPIPB3 MED13L RUNX1 NPIPB5 ANKHD1 ELMO1 GAB2 MAML3 EXOC4 | 1.63e-11 | 193 | 133 | 11 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 198 | 133 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 188 | 133 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 188 | 133 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 188 | 133 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 196 | 133 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-06 | 199 | 133 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-06 | 200 | 133 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-05 | 185 | 133 | 6 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-05 | 190 | 133 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 193 | 133 | 6 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 194 | 133 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 194 | 133 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 194 | 133 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 197 | 133 | 6 | 7a1a3839b2c965136663241b0d4e96c64cfb656a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 198 | 133 | 6 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 198 | 133 | 6 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LA-10._Endothelium_II|LA / Chamber and Cluster_Paper | 5.15e-05 | 134 | 133 | 5 | 048fa6ccf305d22d9a53db4ab385f39f558010d8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.33e-05 | 135 | 133 | 5 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 7.49e-05 | 145 | 133 | 5 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 8.79e-05 | 150 | 133 | 5 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 158 | 133 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 159 | 133 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 161 | 133 | 5 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 161 | 133 | 5 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 161 | 133 | 5 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.30e-04 | 163 | 133 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.41e-04 | 166 | 133 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 167 | 133 | 5 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.76e-04 | 174 | 133 | 5 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.76e-04 | 174 | 133 | 5 | e324320b52c904496e26fcecfa179b3431729ec0 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 1.76e-04 | 174 | 133 | 5 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 177 | 133 | 5 | c6b955765aee8a196fcf4f7bb16139c95b76dc4e | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 178 | 133 | 5 | 8017aaecd6275d8173c516f6f3a68ea991f3c1b0 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 178 | 133 | 5 | 46333db0d205580189062bf9df839c97196ad161 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 182 | 133 | 5 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-04 | 183 | 133 | 5 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 184 | 133 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 185 | 133 | 5 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 186 | 133 | 5 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-04 | 186 | 133 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.40e-04 | 186 | 133 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.40e-04 | 186 | 133 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-04 | 186 | 133 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 187 | 133 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 187 | 133 | 5 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 187 | 133 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 187 | 133 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.46e-04 | 187 | 133 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 187 | 133 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 188 | 133 | 5 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.52e-04 | 188 | 133 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 189 | 133 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.64e-04 | 190 | 133 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 190 | 133 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.64e-04 | 190 | 133 | 5 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 190 | 133 | 5 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.64e-04 | 190 | 133 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 191 | 133 | 5 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 191 | 133 | 5 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.78e-04 | 192 | 133 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 192 | 133 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 192 | 133 | 5 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 192 | 133 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 192 | 133 | 5 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 193 | 133 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 193 | 133 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 193 | 133 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.84e-04 | 193 | 133 | 5 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.84e-04 | 193 | 133 | 5 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.84e-04 | 193 | 133 | 5 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 194 | 133 | 5 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.91e-04 | 194 | 133 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 194 | 133 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 194 | 133 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.91e-04 | 194 | 133 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 194 | 133 | 5 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 194 | 133 | 5 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-04 | 195 | 133 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 195 | 133 | 5 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 2.98e-04 | 195 | 133 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 196 | 133 | 5 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 196 | 133 | 5 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 196 | 133 | 5 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-04 | 196 | 133 | 5 | 1cc2b11764584129703ec61965e8ec4e051464e7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 196 | 133 | 5 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 197 | 133 | 5 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 197 | 133 | 5 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 3.12e-04 | 197 | 133 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 197 | 133 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 197 | 133 | 5 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 197 | 133 | 5 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 197 | 133 | 5 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-04 | 198 | 133 | 5 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.20e-04 | 198 | 133 | 5 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 198 | 133 | 5 | 99be7a7a84199dac598e993a5a0144d9030f13ce | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.35e-06 | 175 | 124 | 8 | 1058_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.71e-06 | 187 | 124 | 8 | 4589_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A | 1.10e-05 | 193 | 124 | 8 | 413_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.10e-05 | 193 | 124 | 8 | 2721_DN | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A | 1.23e-05 | 196 | 124 | 8 | 1399_UP | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 2377_DN | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; PC3; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 5849_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 6708_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.37e-05 | 199 | 124 | 8 | 6804_DN | |
| Drug | ipronidazole | 2.94e-05 | 2 | 124 | 2 | CID000026951 | |
| Drug | galangin | 3.50e-05 | 68 | 124 | 5 | ctd:C037032 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.13e-05 | 170 | 124 | 7 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.45e-05 | 172 | 124 | 7 | 1072_DN | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 8.62e-05 | 191 | 124 | 7 | 3861_UP | |
| Drug | cortisol-21-m-maleimidobenzoate | 8.80e-05 | 3 | 124 | 2 | CID000194518 | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 8.91e-05 | 192 | 124 | 7 | 7526_UP | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 8.91e-05 | 192 | 124 | 7 | 1829_UP | |
| Drug | NSC226080 | TRERF1 RB1 PSMB3 TSC2 ANKHD1 RYR2 BSX CS CSF2RB GYS1 EPAS1 TOP3A CDH16 SMAD3 | 9.36e-05 | 782 | 124 | 14 | CID000005040 |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 3804_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; HL60; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 2975_UP | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 3217_UP | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 5329_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 2708_DN | |
| Drug | Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 196 | 124 | 7 | 7205_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 196 | 124 | 7 | 6053_UP | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 196 | 124 | 7 | 3390_DN | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HG-U133A | 1.01e-04 | 196 | 124 | 7 | 1921_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 3832_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 3748_DN | |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.05e-04 | 197 | 124 | 7 | 161_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 3983_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 2649_UP | |
| Drug | (+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A | 1.08e-04 | 198 | 124 | 7 | 266_UP | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 2638_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 4126_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 3583_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 6044_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 3018_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 6982_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; HL60; HG-U133A | 1.11e-04 | 199 | 124 | 7 | 1727_DN | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; PC3; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 4247_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 6654_UP | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; HL60; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 2732_DN | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 200 | 124 | 7 | 3339_DN | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HG-U133A | 1.15e-04 | 200 | 124 | 7 | 252_UP | |
| Disease | basophil count, eosinophil count | 8.17e-07 | 241 | 123 | 9 | EFO_0004842, EFO_0005090 | |
| Disease | eosinophil percentage of granulocytes | 6.53e-06 | 234 | 123 | 8 | EFO_0007996 | |
| Disease | eosinophil percentage of leukocytes | TRERF1 DOCK3 CHD7 RUNX1 FOXA3 IL18RAP ELMO1 SALL1 CSF2RB GLB1 MBD5 SMAD3 SYMPK | 1.49e-05 | 746 | 123 | 13 | EFO_0007991 |
| Disease | cancer (implicated_via_orthology) | 1.75e-05 | 268 | 123 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Carcinoma, Transitional Cell | 2.58e-05 | 41 | 123 | 4 | C0007138 | |
| Disease | smoking status measurement | TCF20 TOX CHD7 CA10 ELMO1 RYR2 GAB2 SYNGAP1 BNC1 SALL1 IRF2BPL USH2A ALK MAML3 SMAD3 EXOC4 | 2.67e-05 | 1160 | 123 | 16 | EFO_0006527 |
| Disease | IGF-1 measurement | DOCK3 STAG1 R3HDM2 AGBL5 ARID1A SALL1 STARD9 SLIT1 EPAS1 SMAD3 | 3.96e-05 | 488 | 123 | 10 | EFO_0004627 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.38e-05 | 152 | 123 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | testosterone measurement | DOCK3 NCOA6 SHROOM3 UBQLN2 SPEM3 STAG1 R3HDM2 CHD7 ARID1A FOXA3 CDC37L1 TBC1D8 SHROOM4 GYS1 USH2A EPAS1 | 8.20e-05 | 1275 | 123 | 16 | EFO_0004908 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.25e-04 | 61 | 123 | 4 | C1961102 | |
| Disease | mental development measurement | 1.52e-04 | 25 | 123 | 3 | EFO_0008230 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 2.39e-04 | 29 | 123 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 2.39e-04 | 29 | 123 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 2.39e-04 | 29 | 123 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 2.39e-04 | 29 | 123 | 3 | C0014518 | |
| Disease | Fibroid Tumor | 2.56e-04 | 6 | 123 | 2 | C0023267 | |
| Disease | asthma, endometriosis | 2.64e-04 | 74 | 123 | 4 | EFO_0001065, MONDO_0004979 | |
| Disease | Stevens-Johnson Syndrome | 2.64e-04 | 30 | 123 | 3 | C0038325 | |
| Disease | Prostatic Neoplasms | 2.65e-04 | 616 | 123 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.65e-04 | 616 | 123 | 10 | C0376358 | |
| Disease | Bladder Neoplasm | 3.09e-04 | 140 | 123 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.19e-04 | 141 | 123 | 5 | C0005684 | |
| Disease | serum IgG glycosylation measurement | 3.56e-04 | 523 | 123 | 9 | EFO_0005193 | |
| Disease | chronic mucus hypersecretion | 3.57e-04 | 7 | 123 | 2 | EFO_0005673 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Uterine Fibroids | 3.57e-04 | 7 | 123 | 2 | C0042133 | |
| Disease | lymphocyte count | RB1 PCDHGA10 PCDHGA7 PPFIA1 CHD7 PLXND1 MED13L IL18RAP LYST ELMO1 GAB2 BNC1 MST1R PTPRH BTN2A3P LINC00574 | 3.92e-04 | 1464 | 123 | 16 | EFO_0004587 |
| Disease | neutrophil percentage of granulocytes | 3.99e-04 | 228 | 123 | 6 | EFO_0007994 | |
| Disease | Burkitt Lymphoma | 4.56e-04 | 36 | 123 | 3 | C0006413 | |
| Disease | colon cancer (is_implicated_in) | 4.56e-04 | 36 | 123 | 3 | DOID:219 (is_implicated_in) | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 4.75e-04 | 8 | 123 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | Acute erythroleukemia - M6a subtype | 4.75e-04 | 8 | 123 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 4.75e-04 | 8 | 123 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 4.75e-04 | 8 | 123 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 4.75e-04 | 8 | 123 | 2 | C2930974 | |
| Disease | Cornelia De Lange Syndrome | 4.75e-04 | 8 | 123 | 2 | C0270972 | |
| Disease | feeling nervous measurement | 4.90e-04 | 87 | 123 | 4 | EFO_0009597 | |
| Disease | amino acid measurement | 5.62e-04 | 678 | 123 | 10 | EFO_0005134 | |
| Disease | Intellectual Disability | 5.88e-04 | 447 | 123 | 8 | C3714756 | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 6.09e-04 | 9 | 123 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | Adult Hepatocellular Carcinoma | 6.09e-04 | 9 | 123 | 2 | C0279607 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.71e-04 | 41 | 123 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.71e-04 | 41 | 123 | 3 | C0858252 | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 7.59e-04 | 10 | 123 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | S-6-hydroxywarfarin measurement | 9.14e-04 | 368 | 123 | 7 | EFO_0803326 | |
| Disease | creatinine measurement | SHROOM3 STAG1 R3HDM2 ARID1A RGS12 GAB2 TBC1D8 AP4E1 CPNE3 MBD5 EPAS1 SMAD3 | 9.43e-04 | 995 | 123 | 12 | EFO_0004518 |
| Disease | monocyte percentage of leukocytes | TRERF1 CPEB3 CHD7 MED13L RUNX1 ARID1A PTPRH MLLT1 ARHGAP25 MBD5 | 9.97e-04 | 731 | 123 | 10 | EFO_0007989 |
| Disease | Osteosarcoma | 1.00e-03 | 47 | 123 | 3 | C0029463 | |
| Disease | Neuroblastoma | 1.00e-03 | 47 | 123 | 3 | C0027819 | |
| Disease | urate measurement, bone density | 1.17e-03 | 619 | 123 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.20e-03 | 189 | 123 | 5 | EFO_0009932 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.20e-03 | 50 | 123 | 3 | C0023453 | |
| Disease | monocyte count | RALGAPA1 STAG1 R3HDM2 MED13L RUNX1 LYST SGK3 AP4E1 PTPRH BTN2A3P LINC00574 MLLT1 ARHGAP25 MBD5 | 1.23e-03 | 1320 | 123 | 14 | EFO_0005091 |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.35e-03 | 52 | 123 | 3 | C0023452 | |
| Disease | diet measurement | NCOA6 NANOGP8 TCF20 TOX RUNX1 GAB2 BTN2A3P CHD6 MBD5 CDH4 MAML3 EXOC4 | 1.48e-03 | 1049 | 123 | 12 | EFO_0008111 |
| Disease | Small cell carcinoma of lung | 1.50e-03 | 54 | 123 | 3 | C0149925 | |
| Disease | body weights and measures, parental genotype effect measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | Adenocarcinoma Of Esophagus | 1.52e-03 | 14 | 123 | 2 | C0279628 | |
| Disease | body surface area | RALGAPA1 MCPH1 PSMB3 MED13L SPATA31C1 AXIN1 SLIT1 SMAD3 SYMPK | 1.53e-03 | 643 | 123 | 9 | EFO_0022196 |
| Disease | adult onset asthma | 1.53e-03 | 118 | 123 | 4 | EFO_1002011 | |
| Disease | C-reactive protein measurement | TRERF1 DOCK3 NCOA6 TOB2 R3HDM2 CHD7 CEP192 AGBL5 IL18RAP MST1R SALL1 CDH4 MAML3 | 1.60e-03 | 1206 | 123 | 13 | EFO_0004458 |
| Disease | asthma, Eczema, allergic rhinitis | 1.68e-03 | 121 | 123 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | age at menopause | 1.71e-03 | 302 | 123 | 6 | EFO_0004704 | |
| Disease | Situs ambiguus | 1.75e-03 | 15 | 123 | 2 | C0266642 | |
| Disease | puberty onset measurement | 1.89e-03 | 125 | 123 | 4 | EFO_0005677 | |
| Disease | melanoma | 1.95e-03 | 126 | 123 | 4 | EFO_0000756 | |
| Disease | Chromosome Aberrations | 1.99e-03 | 16 | 123 | 2 | C0008625 | |
| Disease | T-Cell Lymphoma | 1.99e-03 | 16 | 123 | 2 | C0079772 | |
| Disease | Autosome Abnormalities | 1.99e-03 | 16 | 123 | 2 | C0004403 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.99e-03 | 16 | 123 | 2 | C3203102 | |
| Disease | rhinitis | 2.25e-03 | 17 | 123 | 2 | EFO_0008521 | |
| Disease | cannabis dependence | 2.50e-03 | 135 | 123 | 4 | EFO_0007191 | |
| Disease | Profound Mental Retardation | 2.78e-03 | 139 | 123 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.78e-03 | 139 | 123 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.78e-03 | 139 | 123 | 4 | C0917816 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 2.81e-03 | 19 | 123 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | hemifacial microsomia | 2.81e-03 | 19 | 123 | 2 | MONDO_0015398 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 2.81e-03 | 19 | 123 | 2 | DOID:4928 (is_marker_for) | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.03e-03 | 69 | 123 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | lifestyle measurement | 3.10e-03 | 235 | 123 | 5 | EFO_0010724 | |
| Disease | dentures | 3.16e-03 | 70 | 123 | 3 | EFO_0010078 | |
| Disease | dental caries, dentures | 3.16e-03 | 70 | 123 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | respiratory system disease | 3.23e-03 | 145 | 123 | 4 | EFO_0000684 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 3.29e-03 | 71 | 123 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | Endometrial Carcinoma | 3.42e-03 | 72 | 123 | 3 | C0476089 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.44e-03 | 21 | 123 | 2 | C1292769 | |
| Disease | Sarcoma | 3.44e-03 | 21 | 123 | 2 | C1261473 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.48e-03 | 148 | 123 | 4 | C0279702 | |
| Disease | eosinophil count | TRERF1 DOCK3 CHD7 RUNX1 FOXA3 IL18RAP ELMO1 SALL1 CSF2RB GLB1 BTN2A3P MBD5 SMAD3 SYMPK | 3.68e-03 | 1488 | 123 | 14 | EFO_0004842 |
| Disease | nasopharyngeal neoplasm | 3.73e-03 | 151 | 123 | 4 | EFO_0004252 | |
| Disease | Nasopharyngeal carcinoma | 3.77e-03 | 22 | 123 | 2 | C2931822 | |
| Disease | serotonin measurement | 3.77e-03 | 22 | 123 | 2 | EFO_0004846 | |
| Disease | body weight loss | 3.77e-03 | 22 | 123 | 2 | EFO_0005245 | |
| Disease | Alzheimer disease, educational attainment | 3.83e-03 | 247 | 123 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | melanoma | 3.90e-03 | 248 | 123 | 5 | C0025202 | |
| Disease | axial length measurement | 4.13e-03 | 77 | 123 | 3 | EFO_0005318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPSLSTTNQQMSPII | 1026 | Q99569 | |
| THHSPQNQFPSLTAM | 491 | Q96KV6 | |
| QNSPQMKNSPSFPFH | 656 | Q8NDL9 | |
| MSAENNQLSGASPPH | 1 | Q5W0A0 | |
| SPDQNSMLSQLASNP | 2366 | Q09472 | |
| PQSTPQHCFSAMTNI | 556 | Q99814 | |
| LDLEMLSSPQHSPVN | 481 | Q9H2F5 | |
| HRQTLSPVPQQFSMS | 551 | P51689 | |
| SSSMQLAHQSPLQPL | 286 | Q9N2J8 | |
| FINHVNPAMDFTQTP | 361 | Q92556 | |
| PQMSQFQSLTHQSPP | 1071 | O60885 | |
| MTLHNNSTTSPLFPN | 1 | P20309 | |
| NPSSIHPFENLISNM | 226 | Q01954 | |
| QVSHEFPMNFNPSNP | 356 | O75131 | |
| MNLNFTSPLHPASSQ | 1 | Q3C1V8 | |
| HFPTAMTSATLNQPL | 446 | Q6P1W5 | |
| NNMLQPETHIFTAPE | 26 | Q5HYR2 | |
| PIHPSGSLNQMNTQT | 366 | Q9P2D1 | |
| MLAHPPQNLIAQSQS | 131 | Q9UHL0 | |
| SLFANNNMEIFHPPQ | 876 | Q9UPM8 | |
| NNMEIFHPPQSTAAS | 881 | Q9UPM8 | |
| VSSLPFHPQLHPQQM | 591 | Q92617 | |
| PLISQHPQQTSFIMA | 466 | Q9Y2K5 | |
| PLNLPLQNNHTAADM | 591 | P06400 | |
| VLFSPDHPSLENMEQ | 506 | P13056 | |
| THIFMQVADTNDNPP | 436 | Q9Y5G6 | |
| SLLTTHPQPMDQASL | 241 | Q9NV88 | |
| HPQPMDQASLKNSDV | 246 | Q9NV88 | |
| PDPQSANHMNSSLLS | 111 | O15381 | |
| VSSLPFHPQLHPQQM | 511 | F8W0I5 | |
| PNMDPDHLFETISQA | 156 | P49720 | |
| SQASLLHMQNPPFEP | 2211 | O14497 | |
| QVPEHLPFMGSNDLS | 66 | O95256 | |
| HIHMAQSSPAPFQVL | 196 | Q71F56 | |
| SPTSSQMIQQSHDNP | 191 | Q8NEM0 | |
| SSEPSLQFPEINLMN | 91 | Q5T1H1 | |
| THFNADLSQRMTPPV | 606 | Q96JK9 | |
| QNDSFGTQLPPMHQQ | 81 | Q96AE4 | |
| EQPSQSASFTHMPQS | 4321 | Q2LD37 | |
| SASFTHMPQSPNVFN | 4326 | Q2LD37 | |
| LFVPQHILMTSAPNT | 601 | P16278 | |
| QVHPQNIPDSPMANS | 696 | Q9H1B7 | |
| FPSMLNVAANHPNAS | 176 | Q9Y4D7 | |
| HFMLQVADINDNPPT | 441 | Q9Y5H3 | |
| PSENLPLFQLNSQSM | 311 | A0A1B0GTH6 | |
| IDPTASHIPRQSFNM | 496 | Q32MH5 | |
| LSMAATLQHSQPPDL | 251 | Q8WU58 | |
| APLPEISNAHSQQMD | 886 | Q9ULH7 | |
| SPSQPDADSHFEQLM | 26 | Q13136 | |
| VSSLPFHPQLHPQQM | 716 | A8MRT5 | |
| VSSLPFHPQLHPQQM | 721 | C9JG80 | |
| VSSLPFHPQLHPQQM | 731 | E5RHQ5 | |
| PPMTDFFSKQLENNH | 286 | Q96HP4 | |
| TMNPSNFATPQTHKL | 1291 | Q14686 | |
| MLSPAQDSHTNTDLP | 736 | Q96A65 | |
| MTHFLEVNPQADQLP | 491 | Q8WWV6 | |
| LQNAHSMALPALEPS | 391 | P32927 | |
| LSEFPQAVAMQHPNH | 1391 | Q8IZD9 | |
| PEPFNGMVHINTDTQ | 1461 | P17927 | |
| NGTMLFQNFPHHVNP | 131 | Q8NE35 | |
| HSPDAPDFQLQAMIQ | 766 | Q8TD26 | |
| TSVQPSHLFIQDPTM | 681 | O15169 | |
| DNFPTNLHPMSQLSA | 156 | O75390 | |
| SESMFPSQHPVLSSN | 51 | Q9H8X3 | |
| QPSQMHLNSAAAQSP | 1141 | Q86UU0 | |
| PSNPMVLNHLANHFF | 266 | Q6PD62 | |
| ANLTVMDRDQPHSPN | 411 | P55283 | |
| PAALSVISNMNNSPF | 241 | Q99698 | |
| PCSANQLHFTDPSMN | 731 | Q9P267 | |
| QGHLNQNSSPSLMFP | 126 | P31273 | |
| QNMPAAVHALLTQPS | 1241 | Q8TEP8 | |
| NNLPEPDEVMSFQSH | 476 | Q17RS7 | |
| NMTLINFTPSQLPNH | 3251 | Q03164 | |
| FEPSQNHSQGPLRSM | 391 | Q03111 | |
| TPNQPFNSVHLFSFM | 561 | Q86UP6 | |
| FHSLPFSLTKMPNTN | 416 | Q9NQC7 | |
| QRQSFPPVCTHNMLD | 436 | P13807 | |
| QSPVNIETSHMIFDP | 66 | Q9NS85 | |
| TDFPQMQLSLPSDNS | 231 | P51530 | |
| HQMRDLPSQLFEPSS | 1051 | Q9NSC2 | |
| HNPNAGLSDLMSNPV | 4396 | Q92736 | |
| FLQMDSPKHQSDPSE | 116 | Q96BR1 | |
| MSSNRPNLTPQNQHA | 686 | Q16820 | |
| HILSQAPAQPSPDMF | 166 | O75309 | |
| SQSFQPMTVQNHVPH | 276 | Q7L3B6 | |
| SSLPFHPQLHSQQMI | 596 | A6NJU9 | |
| VSSLPFHPQLHPQQM | 721 | A6NJU9 | |
| TFEPPVSNHMQPTLS | 171 | Q9UQC2 | |
| VSNHMQPTLSTSAPQ | 176 | Q9UQC2 | |
| LNHSTAFNPQPQSQM | 226 | Q01196 | |
| GHQALPMPSSFSQRQ | 131 | Q3SY00 | |
| SPQQSIPMAFSQLLH | 1406 | O75445 | |
| SDVTNNLKPSLHPQM | 351 | O75674 | |
| QNALSDMAPHNPHTL | 296 | Q7Z572 | |
| PEQQAFLTQPHSSMV | 156 | Q8WZ73 | |
| ESLQSCMHFQPNSPA | 246 | Q6NSW7 | |
| NHPFSINNLMSEQTP | 301 | P55318 | |
| TMSPLLFQAQPLSHL | 461 | Q8IWB4 | |
| PSSVSHQQFQPLHRM | 286 | Q7Z5V6 | |
| LNHADSDVPPSNTMS | 636 | Q149N8 | |
| HFAQVPQPSVSSNGM | 476 | Q8TF72 | |
| QPPESSQQGSEHLLM | 346 | Q9ULL8 | |
| HATQMNNAVPTSPLL | 231 | B4DS77 | |
| PQNEARSLMPSEINH | 606 | Q6ZUB0 | |
| QLQFPENMGHTNLPD | 4421 | Q9P2P6 | |
| TMSPLLFQAQPLSHL | 321 | P0DKV0 | |
| MKQDFSVPQLPHSSS | 621 | P40967 | |
| QNEPHMPLNATFPDS | 161 | Q15797 | |
| VNMAFSQSNPPSELH | 1476 | Q9UM73 | |
| GNHPMHQQLSDPSTF | 2421 | Q8IWZ3 | |
| TMSPLLFQAQPLSHL | 461 | Q5VYP0 | |
| SSTMSNPDHFPQLLL | 191 | Q8WWB5 | |
| PQNEARSLMPSEINH | 606 | P0C874 | |
| AFLEHMSEVQPDSPQ | 606 | Q9H270 | |
| QTPSPSTLNIDHMEQ | 1001 | Q6GYQ0 | |
| VGHESINNPNPNMLS | 181 | O14924 | |
| EKQNFFHMSSPQNPE | 456 | A0A1B0GUW6 | |
| QLSLQDNLQHMLSPP | 1021 | Q96PV0 | |
| TMSPLLFQAQPLSHL | 461 | Q5VU36 | |
| NLSPNPMSPAHNNLD | 206 | P84022 | |
| PMSPAHNNLDLQPVT | 211 | P84022 | |
| TLPPFMHNTGATDLQ | 66 | Q7RTT5 | |
| NRMLSNESLHPPAFS | 51 | Q9P2N2 | |
| QMAAFHPSSTPNPLE | 31 | P42331 | |
| PLMHPDALVTAFQQS | 446 | O95759 | |
| GSEPDFLHNPQMQIS | 1141 | Q8WVM7 | |
| SPMQFHQNFSPISNP | 356 | Q9UGU0 | |
| FLHMLSNPVDLSNPA | 286 | Q86X10 | |
| SFTPHQQAHIPNSIM | 1081 | Q92797 | |
| SLNRMDNSQHPQPAD | 771 | Q13472 | |
| STFIIPQNMNPEKSH | 256 | Q6ZMW2 | |
| PAFLQQMQNPDTLSA | 431 | Q9UHD9 | |
| DDVTQVRFHPSNPNM | 171 | Q96FK6 | |
| IPNGHNSSLPMVFQD | 846 | Q8IY18 | |
| NSSLPMVFQDLPNTL | 851 | Q8IY18 | |
| NNITTIPVSSFNHMP | 191 | O75093 | |
| NATTAPNPVRNLHME | 381 | Q9HD43 | |
| STSHEMNVRPEQPQF | 1366 | Q04912 | |
| ALHSPTMQQGFTLQP | 456 | O94900 | |
| HPSFPVMQPSLETQA | 91 | Q96M66 | |
| SMHSLNFITANPAPQ | 236 | Q14106 | |
| LSPFSSDINNMPLQE | 1216 | P49815 | |
| QPLNHMNLHPAVSST | 161 | Q9GZV5 | |
| LNNMGPQHQQLSPSA | 461 | Q96PN7 | |
| DMAAPALLNNPVHQS | 206 | Q8TEU8 | |
| SNTMSIHSQQSTPFP | 5011 | Q9UKN1 | |
| NSEAGSHQQLMPPAN | 871 | O94898 | |
| GTPSQNMKLNSHFPS | 601 | P20592 |